Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

FDA Clears Laser for Diabetes Monitoring

Photonics Spectra
Jan 1999
There's good news for diabetics who draw blood to monitor their glucose levels. The US Food and Drug Administration (FDA) has approved the Lasette, a battery-operated Er:YAG laser that can extract blood without the pain associated with metal lancets, for home use. Cell Robotics International Inc. in Albuquerque, N.M., manufactures the device.

Clinical tests revealed that patients who received adequate training with this device were able to perform pinpricks as easily as with lancets. It was effective with both adults and juveniles who have diabetes, a chronic disease that afflicts 15.7 million people in the US.

In the wake of the FDA's clearance, Cell Robotics' stock more than doubled, increasing from $1.81 Dec. 7 to $3.69 Dec. 9.

As We Go To PressBreaking NewslasersPresstime Bulletin

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media
x Subscribe to Photonics Spectra magazine - FREE!